Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue-Reference-Cited by-同舟云学术

Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue

Published:2019-10 Issue: Volume:81 Page:24-40
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Enache Daniela,Pariante Carmine M.,Mondelli Valeria

Funder

National Institute for Health Research

Biomedical Research Centre

South London and Maudsley NHS Foundation Trust

King’s College London

Department of Health

Swedish Society of Medicine

Medical Research Foundation

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology

Reference93 articles.

1. Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder;Altshuler;Bipolar Disord.,2010

2. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder;Aston;Mol. Psychiatry,2005

3. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder;Barley;Schizophr. Res.,2009

4. Myelination: do astrocytes play a role?;Barnett;Neuroscientist,2013

5. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality;Bay-Richter;Brain Behav. Immun.,2015

Cited by 434 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies;Current Pharmaceutical Biotechnology;2024-12

2. Inflammation-related abnormal dynamic brain activity correlates with cognitive impairment in first-episode, drug-naïve major depressive disorder;Journal of Affective Disorders;2024-12

3. Association between chronic disease status and transitions in depressive symptoms among middle-aged and older Chinese population: Insights from a Markov model-based cohort study;Journal of Affective Disorders;2024-10

4. Balancing the mind: Toward a complete picture of the interplay between gut microbiota, inflammation and major depressive disorder;Brain Research Bulletin;2024-10

5. Microglial morphological/inflammatory phenotypes and endocannabinoid signaling in a preclinical model of periodontitis and depression;Journal of Neuroinflammation;2024-09-08